Quantbot Technologies LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Quantbot Technologies LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$380,263
+33.0%
6,683
+2.8%
0.03%
+3.8%
Q2 2022$286,000
+93.2%
6,500
+77.6%
0.03%
+136.4%
Q3 2021$148,000
-41.3%
3,660
-34.1%
0.01%
-45.0%
Q2 2021$252,000
-11.3%
5,550
-18.6%
0.02%
-25.9%
Q1 2021$284,000
+0.7%
6,816
+3.1%
0.03%
-6.9%
Q4 2020$282,000
+184.8%
6,609
+73.7%
0.03%
+163.6%
Q3 2020$99,000
+230.0%
3,805
+232.0%
0.01%
+175.0%
Q2 2020$30,000
+500.0%
1,146
+306.4%
0.00%
+33.3%
Q1 2020$5,000
-88.9%
282
-89.0%
0.00%
-25.0%
Q4 2019$45,000
+200.0%
2,561
+156.1%
0.00%
+300.0%
Q3 2019$15,000
-44.4%
1,000
-37.5%
0.00%
-66.7%
Q2 2019$27,000
-57.1%
1,600
-54.4%
0.00%
-25.0%
Q3 2018$63,000
+117.2%
3,510
+59.5%
0.00%
-20.0%
Q3 2015$29,000
-66.7%
2,200
-64.1%
0.01%
-77.3%
Q1 2015$87,000
+200.0%
6,124
+102.0%
0.02%
+340.0%
Q2 2014$29,0003,0320.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders